Clinical Trial

Ultrasonographic Predictors of Adductor Canal Block Effectiveness in Total Knee Arthroplasty

Recruiting
View on ClinicalTrials.gov →
Summary
Total knee arthroplasty (TKA) is associated with substantial postoperative pain and opioid requirements, making effective multimodal analgesia essential for early mobilization, functional recovery, and reduction of opioid-related adverse events \[1,2\]. Adductor canal block (ACB) has become a key component of enhanced recovery after surgery (ERAS) protocols because it provides effective anterior knee analgesia while largely preserving quadriceps muscle strength \[2-4\]. However, analgesic efficacy after ACB remains variable, and some patients require rescue opioid analgesia despite technically successful block placement \[5\]. Although ultrasound guidance improves block accuracy, factors such as tissue depth, anatomical variations, saphenous nerve visibility, and injectate spread pattern may influence clinical outcomes \[6,7\]. Prospective evidence regarding the predictive value of these ultrasound-derived parameters for ACB analgesic failure remains limited. Therefore, this study aims to evaluate whether preoperative ultrasound-derived tissue and target parameters-including skin-to-target depth, subcutaneous fat thickness, muscle thickness, saphenous nerve visibility, and injectate spread pattern-can predict ACB analgesic failure and early postoperative analgesic outcomes following TKA.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-13
Trial Details
NCT Number NCT07730216
Lead Sponsor Konya City Hospital
Conditions Arthroplasty, Replacement, Knee, Nerve Block Assessment, Pain, Postoperative Arthroscopy
Enrollment 623 participants
Start Date 2026-08-09
Primary Completion 2027-07-13 (estimated)
Study Completion 2027-07-13 (estimated)
Updated on ClinicalTrials.gov 2026-08-12